Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation

被引:116
作者
Ravaioli, M
Grazi, GL
Ercolani, G
Fiorentino, M
Cescon, M
Golfieri, R
Trevisani, F
Grigioni, WF
Bolondi, L
Pinna, AD
机构
[1] Univ Bologna, Dept Liver & Multi Organ Transplantat, SantOrsola Malpighi Hosp, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Onco Hematol, SantOrsola Malpighi Hosp, F Addarii Inst,Pathol Div, I-40138 Bologna, Italy
[3] Univ Bologna, Dept Radiol, SantOrsola Malpighi Hosp, I-40138 Bologna, Italy
[4] Univ Bologna, Dept Internal Med Cardioangiol Hepatol, SantOrsola Malpighi Hosp, I-40138 Bologna, Italy
[5] Univ Bologna, Dept Internal Med & Gastroenterol, SantOrsola Malpighi Hosp, I-40138 Bologna, Italy
关键词
selection criteria; transarterial chemoembolization; survival; recurrence-free survival; hepatocellular carcinoma;
D O I
10.1097/01.TP.0000145892.97114.EE
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The presence of partial necrosis in hepatocellular carcinoma (HCC) nodules is a common histologic finding after liver transplantation, but its correlation with tumor recurrence has never been investigated. Methods. we retrospectively reviewed the outcome of 54 patients with a single histologically proven HCC after liver transplantation. All cases had a survival of more than 6 months, and patients treated preoperatively had a transarterial chemoembolization (TACE) procedure. Since 1996, our center has applied the Milan criteria. Correlations between tumor recurrences and clinicopathologic variables, including the presence of partial necrosis, were performed. Etiologic factors for HCC partial necrosis were also investigated. Results. Sixteen of 54 (29.6%) HCC nodules presented partial necrosis, and 4 (25%) of them developed HCC recurrence compared with 1 of 38 (2.6%) cases without this histologic finding (P<0.05). Partial necrosis was related to TACE procedure (P<0.05), patient age less than 50 years (P<0.05), and tumor diameter greater than 2 cm (P<0.05). Multivariate analysis showed only TACE as an independent variable. The other variables related to the five (9.3%) tumor recurrences were HCC diameter greater than 2 cm (P<0.05), year of liver transplantation before 1996 (P<0.05), and the presence of satellite nodules (P<0.05). The Cox regression analysis showed the presence of partial necrosis as an independent variable related to tumor recurrence. The analysis of the recurrence-free survival confirmed the results of the recurrence rate. Conclusion. Partial necrosis was a risk factor for tumor recurrence after liver transplantation. Patients and procedures should be selected while also bearing in mind the side-effect of incomplete necrosis of the nodules.
引用
收藏
页码:1780 / 1786
页数:7
相关论文
共 52 条
[1]  
AALTOMAA S, 1992, ONCOLOGY-BASEL, V49, P1
[2]  
ADACHI E, 1993, CANCER, V72, P3593, DOI 10.1002/1097-0142(19931215)72:12<3593::AID-CNCR2820721208>3.0.CO
[3]  
2-T
[4]   The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin [J].
Asayama, Y ;
Taguchi, K ;
Aishima, S ;
Nishi, H ;
Masuda, K ;
Tsuneyoshi, M .
LIVER, 2002, 22 (01) :43-50
[5]   PRIMARY-TREATMENT OF HEPATOCELLULAR-CARCINOMA BY ARTERIAL CHEMOEMBOLIZATION [J].
BISMUTH, H ;
MORINO, M ;
SHERLOCK, D ;
CASTAING, D ;
MIGLIETTA, C ;
CAUQUIL, P ;
ROCHE, A .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (04) :387-394
[6]   Liver transplantation for hepatocellular carcinoma [J].
Bismuth, H ;
Majno, PE ;
Adam, R .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322
[7]   Review article: liver transplantation for HCC. Treatment options on the waiting list [J].
Bolondi, L ;
Piscaglia, F ;
Camaggi, V ;
Grazi, GL ;
Cavallari, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 :145-150
[8]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[9]   Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma [J].
Cheng, SJ ;
Freeman, RB ;
Wong, JB .
LIVER TRANSPLANTATION, 2002, 8 (04) :323-328
[10]   Liver transplantation for hepatocellular carcinoma: Should we push the limits? [J].
Durand, F ;
Belghiti, J .
LIVER TRANSPLANTATION, 2003, 9 (07) :697-699